Home / Articles / 🚀 Discover the Top Startups Solving Global Problems – And How You Can Invest in Them!

🚀 Discover the Top Startups Solving Global Problems – And How You Can Invest in Them!

In this video, we highlight a curated selection of high-potential startups currently raising funds through licensed equity crowdfunding platforms. From cutting-edge biotech and medtech to green energy, fintech, and food innovation—these are the ventures reshaping industries and tackling real-world challenges.

June 15, 2025 •

Looking to diversify your portfolio with future-shaping ventures? We’ve done the homework for you! After reviewing 90+ equity crowdfunding platforms, we’ve handpicked some of the most exciting early-stage startups across Europe that are open to investment, with entry points starting from just a few hundred euros.

Apmonia Therapeutics on Capital Cell

Apmonia Therapeutics is a French biotechnology company developing a disruptive therapeutic strategy against cancer, by specifically targeting tumor microenvironment.

Estimated return of 1500% with potential exit in 2028

Industry - HealtTech

Raising- 4.000.000 EUR

Valuation (pre-money) - 18.760.000 EUR

Company and product stage - Premarket/clinical phase

What problem Apmonia Therapeutics is solving?

As life expectancy increases, the likelihood of developing cancer rises—by +55% in 2040 compared to 2020, according to the WHO. Meanwhile traditional therapies for solid tumours—chemotherapy, radiotherapy, and surgery—are unable to cure ~50% of patients, who die within 5 years.

New therapies based on targeted approaches and immunostimulation, while promising, still face several shortcomings in clinical setups: drug resistance and immune evasion, very high production costs, inability to penetrate solid tumours, major side effects.

Apmonia Tx has developed a discovery platform of peptides using powerful computational simulation models together with wet lab validation, to focus on disrupting the tumor ECM. They have several major advantages:

Synthesis is fast and very inexpensive, unlike Mabs and immunotherapies.
We avoid aggregation and degradation problems common to antibodies and peptides through in silico design optimization and peptide cyclisation. This makes them resistant to endo/exonucleases, and has demonstrated long term retention within the tumour.
Smaller size minimizing immune reactions, avoiding off-target effects & hyperactivity seen with MAbs & vaccines.
TAX2 decreased tumour vascularisation and growth, and increased T-cell infiltration in 15 cancer models, with excellent safety profile in toxicology studies.

Oakberry on Tudigo

Oakberry, the world's #1 aai brand

Estimated return of up to 610%

Industry - Foodtech

Company and product stage - Oakberry has 900 stores in 40 countries, with the goal of 1,000 points of sale by the end of 2025.

What problem Oakberry is solving?

Oakberry is the world leader in açaí bowls , born in Brazil in 2016.

Today, Oakberry has 900 stores in 40 countries , with the goal of 1,000 points of sale by the end of 2025 .

The French Acai Company is the French arm of the Oakberry success story.

Positioned in the "healthy fast casual" segment, the brand targets young urbanites and tourists looking for a quick, natural, and delicious alternative. The license covers France, Monaco, and Luxembourg, with a rapid expansion strategy for both owned and franchised outlets.

Oakberry offers a 100% açaí offering , with an exceptional raw product (pure pulp imported from the Amazon), full traceability and a single-product approach that guarantees quality, speed and continuous innovation. All within a "healthy fast casual" concept adapted to current expectations.

The French Acai Company operates the exclusive license in France, Luxembourg and Monaco with a network of its own and franchised stores.

What is Oakberry market potential?

11 billion euros - this is the size of the French superfood market.

+20% - This is the global percentage of veggie/vegan consumption.

Gravitricity on Crowdcube

Gravitricity is a pioneering developer of innovative, long-life, underground energy storage to help support the transition to 100% renewable energy. They are developing technologies to store both power and hydrogen and are now fundraising to support the ongoing development of both technologies whilst continuing their efforts to secure major funding to build two demonstrator projects for each technology.

Industry - Storage /renewable energy

Company and product stage - Strategic commercialisation partnerships for both technologies with ABB and Baker Hughes

What problem Gravitricity is solving?

Problem

Intermittent renewable energy requires storage for energy security. Current battery technology is not able to meet requirements of the wider energy and industrial market and is under scrutiny around safety and use of critical minerals.

Solution

GRAVITRICITY is developing innovative, long-life, underground technologies that store energy safely and deliver it on demand at a lower lifetime cost than current alternatives.

What is Gravitricity market potential?

Following a 76% increase in global storage installations across 2024 alone, the market size is forecast to increase by 10 times to 2035, reaching $1.2tn by 2040.

Viritech on Crowdcube

Viritech is unlocking the potential of hydrogen as a vital clean energy with a goal to revolutionise transportation and distributed power. Our innovative enabling technologies are accelerating the adoption of hydrogen as a viable and scalable alternative to traditional fossil fuels, with no compromise on performance.

Industry - Renewable energy

Company and product stage - Collaboration with Ford | 40t HGV | Strategic collaboration with Nuvera

What problem Viritech is solving?

Problem - Achieving zero emissions by ending the use of fossil fuels is an existential challenge which will require a combination of technologies, and hydrogen power solutions will be an important component.

Solution - Viritech is aiming to develop hydrogen power systems, including hardware, software, power electronics, BMS, and pressure vessel technology intended for the automotive, aerospace, marine and distributed power sectors.

What is Viritech market potential?

The global clean hydrogen market is expected to grow to c.$642bn by 2030, provide 18% of the world’s energy needs, and create 30 million jobs by 2050.

Income on SeedBlink

Invest in loans. Secure and simple.

Industry - Fintech

Raising - 627.000 EUR

Valuation (pre-money) 5.500.000 EUR

Company and product stage - €139.6M in total loans funded, 54% revenue growth YoY (2024)

What problem Income is solving?

Investing in loans has historically been risky for retail investors. Income mitigates these risks through unique security features not found on other platforms, including a compulsory Buyback Obligation and Cashflow Buffer. These mechanisms effectively collateralise non-bank lenders’ listed portfolios, providing investors with additional protection.

Income differentiates itself by integrating robust risk management, financial safeguards, and cutting-edge technology to offer a secure and seamless investing experience.

What is Income market potential?

The European P2P lending market is substantial. It is projected to grow at a CAGR of 25.27% from 2024 to 2031, reaching an estimated value of €180 billion by 2031.

CAESL on Seedrs / Republic

CAESL develops inventive products, including TASHEX, a smart solar add-on, & provides NetZero consultancy

Industry - Renewable energy

Raising - 400,024 GBP

Company and product stage - CAESL has secured pilot projects in the UAE and Singapore, showcasing TASHEX’s 28% and 25% (respectively) boost in solar power output.

What problem CAESLis solving?

TASHEX developed by CAESL is a pioneering British-developed thermal absorber heat exchanger, designed to optimise the performance and longevity of photovoltaic (PV) panels. High ambient temperatures present a significant challenge to solar energy efficiency, as overheating reduces the output power of PV cells and accelerates their degradation. Conventional cooling methods, using substances such as water or phase change materials, are often expensive and complex, making them less attractive for widespread adoption.

TASHEX addresses this issue with an AI- and IoT-driven smart cooling system that actively regulates the temperature of solar panels, even in moderate climates. This patent-protected solution is simple to retrofit onto existing solar systems and integrates seamlessly with new installations, offering substantial benefits for both residential and industrial solar projects.

What is CAESL market potential?

The global solar market is rapidly growing, and is forecast to exceed 2 TerraWatts by the end of 2026. Yet challenges like overheating, high maintenance & costly monitoring limit efficiency.

CAESL addresses these with TASHEX — a smart monitoring & cooling system —positioning us to capture market share in high-radiation and high-energy-cost regions.

Obligate on Seedrs / Republic

Obligate - leading the way to make on-chain capital markets accessible, efficient, and transparent.

Industry - Fintech

Raising -750,001 EUR

Company and product stage - More than $65 million transacted on Obligate / Generated over $1 million annual revenue

What problem Obligate is solving?

Obligate unlocks access to debt capital markets with its Swiss-regulated platform, making it easy to issue and invest in digital securities. Using blockchain and our proprietary eNote™ infrastructure, we offer fast, cost-efficient, and compliant solutions—now opening our equity to the public

What is Obligate market potential?

Obligate leads the fast-growing $12.5B real-world assets tokenization market, focusing on debt and investment products. With 720% annual issuance volume growth at Obligate*, vs. 200% general market growth.

DIAMONTECH AG on Companisto

Co-financing with Samsung for award-winning deep-tech startup for non-invasive blood glucose monitoring.

Estimated return of 1200%

Industry - MedTech

Raising - 7,050,000 EUR

Valuation (pre-money) - 80,837,240 EUR

Company and product stage - Clinical trials showed medical-grade accuracy, with Mean Absolute Relative Difference ~9%, comparable to FDA-approved invasive devices./ Letters of Intent for ~100,000 devices already signed

What problem DIAMONTECH AG is solving?

DiaMonTech is tackling the burden of invasive glucose monitoring for people with diabetes. Traditional glucose measurement methods require frequent finger pricks or inserting sensors under the skin, which are painful, cumbersome, and often not used as frequently as needed due to discomfort.DiaMonTech offers a non-invasive glucose monitoring device based on proprietary mid-infrared laser technology. This patented approach allows accurate glucose level measurement without drawing blood. Devices range from clinical-grade systems to pocket-sized personal devices and future wearables.

What is DIAMONTECH AG market potential?

500 million people worldwide live with diabetes. USA: 34 million have diabetes, and 88 million have pre-diabetes. The company estimates revenue potential of $225 million by 2028 based on sales projections. The total addressable market is significant, given the universal need for painless, accurate glucose monitoring.

CYTOK on Fundernation

Patented 3D printing technology for future-oriented food production

Estimated return of 570%

Industry - Energy storage

Raising - 1.250.000 EUR

Valuation (pre-money) - 6.000.000 EUR

Company and product stage - The proof-of-concept for neighborhood applications demonstrated the potential of CYTOK for supplying energy to residential neighborhoods to Dutch customers. Another proof-of-concept was created for a commercial enterprise for 100% single-phase use of a 900 kWp PV system .

What problem CYTOK is solving?

Renewable energies are on the rise – but what happens to the surplus electricity produced?

The strong growth in wind power and PV systems presents us with a new challenge: creating storage options for surplus green electricity , which have so far been insufficiently available. The energy mix must be not only reliable but also accessible to consumers at competitive prices.

Blackout? Not with us! Our patented power-to-gas technology enables 100% green electricity utilization. We enable the economical and efficient storage of excess electricity by converting it into storable, versatile synthetic natural gas – with all the benefits of proven natural gas technology, but without emissions.

Potential customers – commercial and private property owners, municipal utilities, contracting companies – secure sustainable energy, stable costs and independence from the grid with our innovative CYTOK solutions.

Technology has passed its “baptism of fire” : Since 2020, a system with CYTOK Power-to-Gas technology at Bernsteinsee Hotel GmbH in Lower Saxony has guaranteed a reliable, economical and emission-free energy supply for the entire hotel operation, including the waterski facility.

The market for sustainable energy production, energy supply, and storage is growing inexorably worldwide , necessitating increasing energy storage capacity . The market is estimated at approximately €200 billion in the building sector alone (as of 2024).

Bilihome on Invesdor

Wearable light therapy that transforms neonatal care

Industry - MedTech

Raising - 5,499,845 EUR

Valuation (pre-money) - 8 million EUR

Company and product stage - Successful completion of pre-commercial studies for publication of superiority in natural care and usability.

What problem Bilihome is solving?

Bilihome Jauni is a soft, wearable phototherapy romper that enables effective, hospital-grade treatment while supporting breastfeeding and bonding. The device is safe, CE-in-progress, and designed for both hospital and home settings. Recurring revenue is generated through the garments (Jauni Newborn Kit), which are single use and hold the Jauni system kit during treatment.

The company will launch in The Netherlands in 2025, followed by Germany and the Nordics. Expansion to Asia and the Middle East is planned in the future through distributors and strategic partnerships.